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ABSTRACT 
 
Dystonia is a neurological disorder characterized by excessive involuntary muscle contrac-
tions that lead to twisting movements. The exaggerated movements have been studied and 
have implicated basal ganglia as the point of origin. In more recent studies, the cerebellum has 
also been identified as the possible target of dystonia, in the search for alternative treatments. 
Tiagabine is a selective GABA transporter inhibitor, which blocks the reuptake and recycling 
of GABA. The study of GABAergic drugs as an alternative treatment for cerebellar induced 
dystonia has not been reported. In our study, tiagabine was i.p. injected into kainic acid in-
duced, cerebellar dystonic adult rats, and the effects were compared with non-tiagabine in-
jected and sham-operated groups. Beam walking apparatus, telemetric electromyography 
(EMG) recording, and histological verification were performed to confirm dystonic symptoms 
in the rats on post-surgery treatment. Involuntary dystonic spasm was observed with repetitive 
rigidity, and twisting movements in the rats were also confirmed by a high score on the dys-
tonic scoring and a high amplitude on the EMG data. The rats with tiagabine treatment were 
scored based on motor amelioration assessed via beam walking. The result of this study sug-
gests and confirms that low dose of kainic acid microinjection is sufficient to induce dystonia 
from the cerebellar vermis. In addition, from the results of the EMG recording and the behav-
ioral assessment through beam walking, tiagabine is demonstrated as being effective in reduc-
ing dystonic spasm and may be a possible alternative therapeutic drug in the treatment of dys-
tonia.  
 
Keywords: dystonia, cerebellum, kainic acid, tiagabine, telemetry recording 
 
Abbreviations in the experiment: preS: pre-surgery, postS: post-surgery, sham: sham-
operated group, KA: kainic acid/non-treated group, KA+TGB: kainic acid tiagabine treated 
group, TGB: tiagabine group, BW: beam walking, EMG: electromyography, DV: dorsal-
ventral coordinates, i.p.: intraperitoneal injection. 
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INTRODUCTION 
Dystonia is a neurological disorder char-
acterized by involuntary and prolonged mus-
cle contractions that leads to twisting move-
ments or abnormal posturing (Neychev et al., 
2008). The dystonic symptoms are stereo-
typed and repetitive as a result of the agonist 
and antagonist muscle co-contraction that in-
duce affected body parts to over twist (Tana-
be et al., 2009). When the abnormal move-
ment continues for a period of time, unaf-
fected body parts are forced into stiff abnor-
mal posture, relatively (LeDoux and Brady, 
2003; LeDoux, 2011). Dystonia can also be 
task-specific, where patients are normal until 
they begin to perform certain tasks, such as 
the writing or playing a musical instrument 
resulting in writer’s cramp or musician’s 
cramp (Quartarone et al., 2006). Dystonia is 
regionally specific such as oromandibular 
dystonia that interferes with speech, blephar-
ospasm that leads to the involuntary closing 
of the eyelids (Breakefield et al., 2008), and 
cervical dystonia that causes uncontrolled 
neck movement (van de Warrenburg et al., 
2007).  
It was believed that dystonia is an inher-
ited disorder and is age-onset dependent, 
considered as primary dystonia, since no neu-
rological lesions have been found in associa-
tion with the disorder (Bhidayasiri, 2006). 
Some cases of dystonia may accompany oth-
er neurological disorders such as brain injury 
or Parkinson’s disease; they are categorized 
as secondary dystonia (Breakefield et al., 
2008). Although dystonia has recently been 
successfully treated by deep brain stimulation 
(DBS) in specific regions of basal ganglia 
(Krauss, 2002; Ostrem and Starr, 2008), the 
origin and neural mechanisms of dystonia in-
volving alternative brain circuitry have not 
been explained.  
Many GABA transporter subtypes have 
been cloned as the target for treatment of 
convulsions and seizures (Madsen et al., 
2007; Roth and Draguhn, 2012). The GABA 
molecules that encounter uptake by trans-
porters (GAT1, GAT3) at the neuronal ter-
minals can be recycled in the process of 
GABA transmission (Madsen et al., 2010). 
GAT1 has been found in the cerebellar lay-
ers, with high concentration in the Purkinje 
cell layer and molecular layer (Itouji et al., 
1996). Tiagabine (TGB) is a GAT1 inhibitor, 
which enhances GABA effects (Madsen et 
al., 2011) and controls CNS excitability 
(Schousboe et al., 2004). As a lipophilic de-
rivative of nipecotic acid, TGB crosses the 
blood-brain barrier to modulate intra-
synaptic GABA reuptake (Azar and Abou-
Khalil, 2010), but does not increase GABA 
concentration in the cerebrospinal fluid 
(CSF) (Angehagen et al., 2003). Tiagabine 
has been investigated as an anti-seizure 
treatment in the GABAergic system. In hu-
man clinical studies, tiagabine was well tol-
erated and did not affect GABA plasma con-
centration (Azar and Abou-Khalil, 2010; 
Crawford et al., 2001). Although some pa-
tients experienced side effects including diz-
ziness, there were significant reductions in 
partial, complex partial and generalized ton-
ic-clonic seizures (Crawford et al., 2001), as 
well as transient acute dystonic movements 
(Wolanczyk and Grabowska-Grzyb, 2001). 
TGB also reduces convulsions and ataxia 
(Madsen et al., 2011), and alleviates muscle 
spasticity induced by transient spinal ische-
mia (Kakinohana et al., 2012). 
Some studies have investigated involve-
ment of cerebellar lesion in dystonic rigidity; 
however, research on possible pharmacologi-
cal treatment for dystonia remains limited. 
The aim of the present study was to investi-
gate tiagabine as a possible treatment for 
kainic acid induced dystonia in the cerebel-
lum.  
 
MATERIALS AND METHODS 
Animals 
Adult male Sprague Dawley rats (11 
weeks old, weighing 250-270 g) were ob-
tained from the National Laboratory Animal 
Center, Thailand. The rats were kept individ-
ually in the stainless steel, solid bottom, 
opened top cages with a 12/12 light-dark cy-
cle, and with rat chow and water ad libitum. 
Animals were weighted and fed every day at 
the same time. All experimental procedures 
were approved by the Animal Care and Use 
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Committee of the Mahidol University, Thai-
land (MB-ACUC 2012/02). The experi-
mental procedure of this study is summarized 
in Figure 1. 
 
Concentration and coordinate assessment  
Kainic acid and tiagabine concentration 
assessment was performed before the onset 
of the experiment in order to select kainic ac-
id concentration; microinjection coordinates 
in the cerebellum, the animal tolerance to the 
drug and the treatment outcome. In the con-
centration comparison testing, kainic acid 
concentration and dorsal-ventral (DV) coor-
dinates were observed as part of the rat’s re-
sponse after they awaked from anesthesia. In 
addition, the tolerance to drugs the next few 
days after the kainic acid microinjection was 
recorded (Figure 2A). Tiagabine concentra-
tion was also investigated in the concentra-
tion comparison testing (Figure 2B). The aim 
of the second concentration comparison test-
ing was to consider different concentrations 
of tiagabine i.p. injection and to observe the 
drug efficiency 90 minutes after the first in-
jection. Dystonia behavior phenotype scoring 
(Table 1) and beam walking scoring (Table 
2) were used. Abnormal posture of dystonic 
rats were also observed as in Figure 2C.  
 
 
Table 1: Dystonia behavioral phenotype 
The behavior table describes the posture, walk-
ing ability and steadiness of the rats after kainic 
acid surgery. Dystonia of score 0 is normal while 
6 represents a serious dystonic condition with 
seizures and involuntary rigidity. Normal rats 
scored 0 to 1 and dystonic rats scored 4-6. 
Score Behavior 
0 Normal motor behavior 
1 Slightly slow or abnormal motor be-
havior 
2 Limited walking or moving unless dis-
turbed, sometimes has abnormal pos-
ture with or without frequent falls 
3 Limited walking or moving when dis-
turbed, frequent abnormal postures, 
frequent falls but upright most of the 
time 
4 Almost cannot walk or move, abnor-
mal posture, not upright most of the 
time 
5 Prolonged immobility in abnormal 
posture 
6 Twisting movement, “swimming” in-
side the cage 
 
 
 
Figure 1: Experimental outline 
The experimental outline is divided into 2 parts, pre-surgery and post-surgery, where the day of the 
stereotaxic surgery is regarded as day 0. About one week before the stereotaxic surgery (-8 and -7 
day), the rats were trained for beam walking for the 1st time (BW1). The next day, the rats received a 
telemetry implant (-6 day) and were allowed to rest for a few days before their 2nd training session for 
beam walking and the pre-surgery EMG recording (-1 day, BW2, preS EMG). On the day of the sur-
gery, they were divided into 4 groups: the sham group with saline injection, the KA group with kainic 
acid injection, the KA+TGB group with kainic acid injection and tiagabine i.p. injection, and the TGB 
group with tiagabine i.p. injection only. All rats were recorded for post-surgery EMG (postS EMG) im-
mediately after they recovered from surgery. Another recording was conducted at 90 minutes, 7th, 
22nd, 30th, and 48th hours after surgery for the sham and the KA group, while the KA+TGB and the 
TGB groups received another tiagabine i.p. injection at 90 minutes after surgery and recorded for EMG 
one hour later (1.30 h), and continued at the 7th, 22nd, 30th, and 48th hours post-surgery. At the 49th 
hour post-surgery, all rats were tested in the 3rd beam walking session and then sacrificed 3 days after 
the surgery. BW1 and BW2 are considered as pre-surgery BW testing. BW3 is considered as post-
surgery testing. BW, beam walking; preS, pre-surgery; EMG, electromyography; sham, sham-
operated; KA, kainic acid; KA+ TGB, kainic acid with tiagabine treatment; TGB, tiagabine only; i.p., in-
traperitoneal; h, hour; postS, post-surgery  
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Figure 2: Concentration-coordinates assessment  
(A) Kainic acid concentrations were matched with distinct dorsal-ventral coordinates of the rat brain to 
determine the rat behavior and response after the stereotaxic surgery. In the first group of testing (trial 
1 to 4), kainic acid at 3 and 5 µg/µl was injected to a depth of 3.5 mm, which revealed normal move-
ments, giving a dystonia score of 0 and a beam walking score of 10. With further injection to the dorsal 
location of the brain, where DV was at 4 or 5 mm (trial 5 to 9), the rats showed rotating and over-
excited epileptic-like seizures, with a dystonia score of 6 and a beam walking score of 0 and 1. There-
fore, the kainic acid concentration was reduced to 4 µg/µl and then re-tested with 3 µg/µl (trial 10 to 
12) the rats showed stiffness, with the dystonia scores of 4 and 5, and the capacity to hold on the 
beam (beam walking scores of 3). 
 
 
 
(B) With the confirmation of kainic acid concentration at 3 µg/µl and DV 5 mm, tiagabine concentration 
was set at with 2 mg/kg. The figure shows that the rats are steadier in the upright position, with less ri-
gidity and a capacity to walk on the beam after one dose of tiagabine. The dystonia score was 2 to 3 
and the beam walking score was 4 to 5. 
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(C) The rats were observed with trunk twisting (1, 5) and hunchback (1, 4, 6), head and tail unsteadily 
swinging (3, 4), limb stiffness (2, 3, 6) and with dystonic seizure after awakening from the stereotaxic 
surgery. KA, kainic acid; DV, dorsal-ventral coordinates; BW, beam walking; TGB, tiagabine; i.p., in-
traperitoneal; ds, dystonia scores from Table 1; bws, beam walking scores from Table 2. 
 
 
 
Table 2: Beam walking observation 
This table describes the motor behavior and as-
signs the scores to individual rats while they were 
moving along the beam walk apparatus. The 
scores depended on the rats’ behaviors, which 
allowed a score range of 0 to 10.  
Score Behavior 
0 No behavior, complete paralysis,  
no weight bearing 
1 Poor weight bearing, cannot step 
up, fall 
2 Minor weight bearing, can walk only 
1-2 steps, fall 
3 Mild weight bearing, can walk more 
than 2 steps, fall 
4 Good weight bearing, can walk few 
steps, many falls 
5 Good walking, but taken time long-
er than 60 seconds 
6 Good walking, taken time within  
60 seconds, 4-5 foot slips 
7 Good walking, taken time within  
60 seconds, 3-4 foot slips 
8 Good walking, taken time within  
60 seconds, 1-2 foot slips 
9 Good walking, taken time within  
30 seconds, no foot slips 
10 Good walking, taken time within  
15 seconds, no foot slips 
Telemetric transmitter implantation 
Telemetric transmitter (TA11CTA-F40, 
Data Sciences International, St. Paul, MN, 
USA) was prepared before the surgery. Insu-
lation tubing of the transmitter electrode was 
removed from the distal part of the lead and a 
loop was formed (Cesarovic et al., 2011). 
The transmitter was then sterilized with Sep-
tichlor. Rats were anesthetized with Isoflu-
rane, 3.5 % in 100 % oxygen). Following 
midline abdominal incision, the transmitters 
were implanted intraperitoneally. The elec-
trodes were tunneled subcutaneously and 
fixed to the gastrocnemius and tibialis anteri-
or muscles using silk sutures (Cesarovic et 
al., 2011). Carproten (Laboratonos, Pfizer, 
rail) 2.5 mg/kg and Enrofloxacin (General 
Drugs House Co., LTD, BKK, Thailand) 
were injected to reduce pain and prevent in-
flammation every 12 hours, for 3 days. 
 
Stereotaxic surgery and tiagabine injection 
After the telemetry implantation, the rats 
were randomly divided into 4 groups. There 
were the sham-operated group (sham), the 
kainic acid group (KA), the kainic acid with 
tiagabine treatment group (KA+TGB), and 
the tiagabine group (TGB). The sham, KA, 
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and KA+TGB groups received stereotaxic 
surgery. On the day of the surgery, all the rats 
were weighed and abstained from food and 
water from the night before. Isoflurane 
(3.5 % in 100 % oxygen) was used in this 
surgery as anesthesia. After the rats were ful-
ly anesthetized, a midline incision was made 
in between the rat’s’ ears. The skull was 
drilled at the midline above the cerebellum 
and 1 µl of kainic acid (Sigma-Aldrich, 
3 µg/µl) was microinjected (AP from interau-
ral line: -2.4 mm, DV: -5 mm), for both the 
KA and the KA+TGB groups (Paxinos and 
Watson, 1982). Tiagabine (Sigma-Aldrich, 
2 mg/kg) was injected i.p. 5 minutes after the 
kainic acid microinjection. The sham group 
was microinjected with normal saline in 
placed of kainic acid. The tiagabine group re-
ceived tiagabine injection at the same time, 
with the same concentration instead of re-
ceiving stereotaxic surgery. The concentra-
tion of kainic acid (3 µg/µl) and tiagabine 
(2 mg/kg), as well as dorsal ventral coordi-
nates (DV: -5 mm) had been confirmed with 
preliminary experimentation (Figure 2). Once 
the rats were awakened from the anesthesia, 
as mentioned previously in the section of te-
lemetry implantation, 2.5 mg/kg each of 
Carproten and Enrofloxacin were injected in-
traperitoneally and subcutaneously to reduce 
pain and prevent inflammation every 12 
hours, for 3 days.  
 
Dystonic movement observation and EMG 
recording  
The rats were moved from the surgery 
room to record their EMG amplitude and 
movements immediately after they recovered 
from anesthesia. Involuntary twisting and ri-
gidity were scored using the dystonic pheno-
type table (modified from Pizoli et al., 2002; 
Jinnah et al., 2005; and Alvarez-Fischer et 
al., 2012, Table 1).  
A research assistant observed and meas-
ured the scores according to the assigned Ta-
ble 1 to avoid possible bias. A score of 1 rep-
resents a behavior pattern that reflects normal 
motor behavior, with normal posture. A score 
of 2-4 indicates dystonia with increasing se-
verity. If limited walking and movement 
were shown, the rat was disturbed by touch. 
If there was no walking or moving at all and 
the rat couldn’t stay in an upright position, it 
was lifted by tail and placed down again to 
encourage movement, which often preceded 
the dystonia (Pizoli et al., 2002). The rat was 
observed lying still with continuous pro-
longed rigidity, giving a score of 5. If one 
showed twisting movement, it would be giv-
en score of 6. According to previous studies, 
dystonic rats scored about 4, 5, and 6. Nor-
mal rats scored 0 or 1. Therefore, the present 
study would also consider scores 4, 5, and 6 
for dystonic rats, and scores 0 and 1 for 
sham-operated rats.  
At the same time, for dystonic testing and 
scoring, the rats were recorded for their 1st 
post-surgery EMG amplitude. Each EMG re-
cording was 30 minutes and the rats were 
taken for recordings at 90 minutes, 7 hours, 
22 hours, 30 hours and 48 hours after surgery 
(Figure 1). Each EMG recording was video-
taped for further comparison and analysis.  
 
Beam walking assessment 
The aim of the beam walking apparatus 
was to measure the foot slip and the latency 
to transverse the beam for motor coordina-
tion and balance (Carter et al., 2001). The 
size of the beam used in this parameter was 
50 mm x 150 cm. The starting point was 
marked at the 0 cm line and the endpoint at 
the 110 cm. Every 10 cm was labelled with a 
permanent ink to record the distance. A net 
was attached under the beam to prevent inju-
ries from falling and escaping. Two 40-watt 
lamps were set above and at the starting point 
as an adverse stimulus and a goal box was set 
by the end point to encourage forward 
movement (Carter et al., 2001). A video re-
cording camera was fixed in front of the 
starting point (Stanley et al., 2005). Each rat 
was trained with 3 consecutive trials in 3 
days (Luong et al., 2011), including 2 days 
before the telemetry implant (BW1, Figure 1) 
and 1 day after the implant (BW2, Figure 1), 
as pre-surgery session. For the post-surgery 
session, the rats were given 60 seconds on 
the bridge per trial and the one that fell 
would be returned to the spot of the fall 
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(Stanley et al., 2005). For the ones that failed 
to pass the bridge within 60 seconds, the dis-
tance travelled was recorded. The time and 
distance of travel were recorded for each tri-
al, before and after the surgery. The rat be-
havior on the beam was observed and scored 
for comparison between groups using the 
beam walking testing (Table 2, modified 
from Anand et al., 2011). Weight bearing and 
walking ability were used to determine the 
scores. Animals with no weight bearing were 
given 0 to 1 points, ones with minor or mild 
weight bearing were given 2 to 3, and ones 
with good weight bearing were given 4-5 
points. The ones able to walk within 60 sec-
onds with minor foot slips were given 6 to 10 
points (Anand et al., 2011). The immobilized 
ones on the beam were given less points and 
the ones that passed the beam were given 
higher points. The scores given are different 
from the dystonic scores. The scores were as-
signed by a research assistant to avoid possi-
ble bias.  
 
Animal sacrifice and brain collection 
After the perfusion procedures, brains 
were collected and post fixed with 4 % for-
maldehyde for one week and then changed to 
30 % sucrose solution. The brain was sec-
tioned in paraffin sections with microtome. 
The sections were stained with hematoxylin 
and eosin staining (H&E staining), and taken 
for whole brain imaging for needle tracing. A 
stereomicroscope was used to take a whole 
brain image, with an objective lens of 1.25X. 
EMG data acquisition and analysis 
The analogue EMG was digitized at 1 
KHz and acquired using PowerLab A/D con-
verter and Chart 5.4 software (AD Instru-
ments, Australia) (Ngampramuan et al., 
2008). The results measured the peak ampli-
tude of muscle contraction after kainic acid 
microinjection and/or tiagabine i.p. injection 
for 30 minutes. EMG variability analysis in 
the amplitude domain was performed using 
Chart 5.4 software.  
 
Data collection and analysis  
One-way ANOVA with Turkey’s multi-
ple comparison tests was used to calculate 
the statistical differences for dystonic behav-
ioral phenotype score, EMG amplitude com-
parison, and beam walking observational 
scoring test. Sham-operated group and exper-
imental groups were compared to reach sta-
tistical difference when p value is less than 
0.05. Analysis was performed using Prism 
(GraphPad) software. 
 
RESULTS 
Determination of drug concentration and 
coordinates for the microinjection 
Using concentration-coordinates table 
(Figure 2A), the animal status was scored af-
ter awakening from surgery. It indicated the 
immediate tolerance of a rat towards the 
drug. When tested with various concentra-
tions of kainate (1, 3, and 5 µg/µl) to DV 
3.5 mm, only the concentration of 5 µg/µl re-
sulted in the expression of minor abnormal 
movements, with a dystonia score of 1 (ds:1), 
obtained from Table 1. However, when run-
ning on the beam, there was no loss of bal-
ance or the capability of weight bearing, and 
the rats that could walk across the beam 
scored a 10 for the beam walking observation 
(bws:10, obtained from Table 2). When mi-
croinjection was made at the depth of 4 to 5 
mm, the rats could not tolerate the drug tox-
icity, expressing their intolerance by over-
twisting and running in circles inside the 
cage (ds: 6), which resulted in bleeding from 
their mouth. The rats became over exhausted 
and paralyzed the day after the surgery (ds: 
6), some even died before the end point of 
the experiment. As DV was confirmed to 
cause the lesion, we needed to keep the ani-
mals alive by reducing the kainic acid con-
centration. After a few trials of 3 µg/µl vs. 
the 5 mm testing, we agreed on the degree of 
stiffness and rigidity (ds: 4, 5) as well as the 
ability to hold on the beam (bws: 3), which 
was considered as the optimal concentration 
and coordinates (Figure 2A). In this study, 
2 mg/kg tiagabine concentration was i.p. in-
jected post-kainic acid microinjection (Figure 
2B). This concentration was also examined 
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with kainic acid concentration and DV coor-
dinate obtained from Figure 2A. The animals 
showed more steadiness and calmness 80 to 
90 minutes post-surgery (ds: 2, 3) and were 
able to walk on the beam (bws: 4, 5).  
The abnormal behavior was expressed af-
ter the rats awakened from the surgery. Limb 
stiffness and rigidity, and twisting trunk 
could be observed (Figure 2C, 1 and 5). 
Some rats expressed a hunchback posture, ly-
ing on one side with limbs freely swinging 
(Figure 2C, 4). Some could stand on their 
feet, but if the tail was lifting up, their limbs 
would attach against their trunk, indicating 
no support from the lower part of the body 
and hind limbs (Figure 2C, 6). The day after 
the surgery, although the rats started eating 
and drinking, they still experienced limb 
stiffness with their tails swinging in various 
directions from time to time (Figure 2C, 2 
and 3). 
 
Test for disability scoring for dystonic  
severity 
After the animals awakened from anes-
thesia, they had post-surgery EMG record-
ings. The abnormality and rigidity of the dys-
tonic seizure was videotaped for a later dys-
tonic scoring by a third person. The severity 
of the dystonic seizure within the period of 
120 minutes post-surgery was given scores 
according to Table 1. 
According to the graph, the KA group 
maintained a score between 5 and 6; in con-
trast, there was a score variation in the 
KA+TGB group, which finally stabilized at 
60 minutes post-surgery (Figure 3). There 
was a little shift in scores from 100 minutes 
until 120 minutes post-surgery, where the 
KA group (scores 4.75, 4.75, 4.75, in aver-
age, p<0.05) scored slightly less compared 
with the KA+TGB group (scores 5, 5.25, 5.5, 
in average), which correlates with data on the 
EMG observational scoring table at the 90 
minutes (Figure 4). These phenomena sug-
gest that tiagabine treatment meets the peak 
efficiency, and the acute injection of kainic 
acid functioned as the stabilizing effect of the 
dystonic seizures. Please refer to supple-
mental data (S1-Table 1) for complete scores 
of individual rats. 
 
 
 
Figure 3: Dystonic behavioral phenotype score 
This Figure shows the behavioral observation within 2 hours duration post-surgery for 4 groups: sham, 
KA, KA+TGB, and TGB. The scores were obtained from Table 1. The KA group shows a gradually 
higher score compared to sham (***c) and KA+TGB (*b). KA+TGB also had higher scores compared 
with sham (***a). The TGB group did not go through the stereotaxic surgery, so they remained steady. 
Significantly different value: ***a/c, p<0.001; *b, p<0.05; Sham, sham-operated; KA, kainic acid; KA+ 
TGB, kainic acid with tiagabine treatment; TGB, tiagabine only group. 
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Figure 4: EMG amplitude comparison 
This Figure compares the average EMG amplitude between the 4 groups; sham, KA, KA+TGB and 
TGB. The kainic acid group had significant gradual bursting in the EMG with more severity in dystonic 
rigidity and muscle spasm compared with sham (***a), with KA+TGB (*c,); with TGB group (***b). The 
numbers above, or beside the plotted points, show the mean ± SEM (standard error of mean) for only 
the treatment group (KA+TGB) and the non-treatment group (KA). Significantly different value: ***a/b, 
p<0.001, *c, p<0.05. preS, pre-surgery; postS, post-surgery; m, minute; h, hour; Sham, sham-
operated; KA, kainic acid; KA+ TGB, kainic acid with tiagabine treatment. TGB, tiagabine only. 
 
 
 
Intra-muscular EMG recording 
After the rats received the EMG teleme-
try implantation, there were seven EMG re-
cordings (preS, postS, 90 minutes, 7 hours, 
22 hours, 30 hours and 48 hours) (Figure 1). 
Each EMG recording was 30 minutes, except 
for the pre-surgery, 15 minutes. 
For post-surgery recordings, the rats were 
recorded only after awakening from anesthe-
sia. The KA group showed most exaggerated 
muscle contractions compared to the sham, 
KA+TGB and TGB groups (Figure 4). There 
was a high bursting frequency post-surgery 
(42.199±11.122), although muscle was re-
laxed with less amplitude at 90 minutes post-
surgery (27.468±11.091), the amplitude was 
stabilized at the 7th hour post-surgery 
(35.056±8.924) and gradually increased until 
the 30th hour post-surgery (50.056±5.862). 
Please refer to supplemental data (S2-Table 
1) for the complete standard deviation value. 
Kainic acid-injected rats expressed high-
est amplitude in muscle contraction, which 
was significantly different when compared to 
sham-operated animals (p< 0.001). The KA 
group also expressed significantly higher 
amplitude compared with the KA+TGB 
group (p< 0.05). In addition, the KA group 
also showed significant difference compared 
to the TGB group (p< 0.001). In comparison 
with the KA group, the KA+TGB group 
showed an increase in amplitude gradually 
from postS (20.809±4.058) to 90 minutes 
(24.732±5.341), and also stabilized at 7 hours 
(22.456±3.885). From the graph, the KA and 
the KA+TGB groups composed a correlated 
slope from 7 hours to 48 hours (Figure 4). 
Please refer to supplemental data (S2-Table 
1) for the complete standard deviation value. 
 
Beam walking analysis  
All rats were trained for beam walking 
for 2 sessions before the kainic acid mi-
croinjection (BW1 and BW2, Figure 1). Af-
ter full recovery from the kainic acid mi-
croinjection, the rats were required to walk 
on the beam again (BW3, Figure 1). The 
purpose of the third attempt was to record the 
efficacy of the tiagabine treatment in that 
case of kainic acid excitotoxicity in the cere-
bellar cortex, as well as to make a compari-
son with the non-treated and pre-surgery 
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groups. In this behavioral apparatus, we 
quantified not only the locomotion, but also 
the observation scores on how the animals 
responded to the beam walking after the sur-
gery, with/without tiagabine treatment (Table 
2). The scoring was given by a third person 
to avoid possible bias.   
As illustrated in Figure 5, the post-
surgery response reached a statistical differ-
ence compared to the pre-surgery condition. 
The kainic acid group had difficulty in 
weight bearing and was very sensitive when 
touching the beam (scored 1.57 in average). 
Post-surgery KA expressed a significantly 
different reaction towards the beam when 
compared with the post-surgery sham group 
(scored 10 in average, p<0.01), KA+TGB 
(scored 6 in average, p<0.5), and TGB 
(scored 8 in average, p<0.01) groups. 
KA+TGB rats had limited weight bearing, 
but could hold onto the beam with their limbs 
and crawl across the beam with some help 
(scored 6 in average), although it took longer 
time (Figure 6). TGB had no significantly 
different motion when touching the beam 
(scored 8 in average). They had good weight 
bearing and good crossing time, except for a 
few foot slips. Please refer to supplemental 
data (S3-Table 1) for the complete scores of 
individual rats. 
Each rat was compared before and after 
the surgery to observe their behavioral 
changes, especially with the tiagabine treat-
ment. In Figure 6A, KA group had taken a 
significantly longer duration in holding on 
the beam (45 seconds in average), when 
compared with the sham (12 seconds in aver-
age, p<0.0005) and the TGB groups (17 sec-
onds in average, p<0.005), which also spent 
more than 50 % of the time crossing the 
beam when compared with KA+TGB. De-
spite spending longer time on the beam walk-
ing task, rats in the KA group failed to pass 
the 110 cm beam completely (average 36 cm, 
Figure 6B). For the treatment group, alt-
hough the rats did not completely traverse the 
beam either, they managed to spend signifi-
cantly less time on the beam (25 seconds in 
average, p<0.05) and completed the task de-
spite foot slips and the fails, with the distance 
travelled of 100 cm. 
 
 
Figure 5: Beam walking behavioral observation 
The scores were obtained from Table 2; when the rats were running or holding onto the beam, with the 
objective of quantifying the rats’ motor behavior and balance. The KA group, compared to the sham 
group (**a) and the TGB group (**b), expressed most severe dystonic seizures with difficulty staying 
on the beam or starting walking. The average score was 1.57 for the KA+TGB group compared with to 
KA group (*p<0.5). The average score of 6 was generally given to the rats for walking through the 
beam within 60 seconds with fewer falls and significantly different value: **a/b p< 0.01, *p<0.5. preS, 
pre-surgery; postS, post-surgery; Sham, sham-operated; KA, kainic acid; KA+TGB, kainic acid with ti-
agabine treatment. TGB, tiagabine only. 
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Figure 6: Time and distance crossed the bridge 
These two Figures describe time and distance used to cross the beam in the 4 groups: sham, KA, 
KA+TGB, and TGB groups. (A) In comparing the pre- and post-surgery data for each group, all the 
rats used significantly longer time after surgery (KA: *a; KA+TGB: *a; TGB: *a). After the surgery, KA 
also spent significantly longer time (45 seconds in average) than sham (***b), KA+TGB (*b), and TGB 
(**b). (B) Distance in crossing the beam. Although the KA group spent the longest time on the beam, 
this group only travelled 36 cm on average. KA+TGB, the treatment group, travelled 70 cm on aver-
age. Significantly different value: *a/b, p<0.05, **b, p<0.005, ***b, p<0.0005. preS, pre-surgery; postS, 
post-surgery; Sham, sham-operated; KA, kainic acid; KA+ TGB, kainic acid with tiagabine treatment; 
TGB, tiagabine only. 
 
 
Histological imaging 
All brains were collected, sectioned and 
stained with H&E to observe the morphology 
of cerebellar tissue and cells, especially the 
lesion parts. For the KA and KA+TGB 
groups, there were obvious needle traces, 
fragmentation, cell loss and fibrous tissue 
development (Figure 7). When compared 
with the distinct cerebellar layers in the sham 
group, cell loss and fragmentation indicated 
layers of atrophy and enlargement of the in-
tra-layer space rather than complete layers 
(Figure 7B, C). When observed at higher 
magnification (10X), the KA group showed 
thinner layers, indicating cell loss, which is 
in contrast with the KA+TGB sections, 
where some regions of the cerebellar layer 
showed fibrosis and fragmentation (Figure 
7E, F). Despite different degrees of tissue at-
rophy, there was significant degeneration in 
the cellular morphology of the KA+TGB 
group and the non-treated KA group.  
Limitation of the study 
Further molecular analysis or quantitative 
cell number estimation could be performed if 
the improvement of motor function resulted 
from tiagabine treatment and/or cellular plas-
ticity and adaptation. Although preliminary 
study was performed to determine the suita-
ble kainic acid concentration, electroenceph-
alography (EEG) may also have been re-
quired to determine whether the dystonic sei-
zure we induced by kainic acid injection is 
indeed dystonia rather than some other cere-
bellar syndromes, such as epilepsy and atax-
ia. Pizoli’s study with kainic acid-induced 
cerebellar dystonia suggests that this kind of 
stiffness and rigidity can be considered as 
dystonic symptoms after EEG measurement, 
which was compared with the effects of other 
glutamate drugs in their study (Pizoli et al. 
2002). 
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Figure 7: Histological images 
These Figures indicate cell loss and molecular layer fragmentation compared to the sham-operated 
group. The sham group shows dedicated cell layers of the cerebellum (A, D). There is needle tract le-
sion and cell loss in the KA group (B*) and layer disconnection in the KA+TGB group (C*). With higher 
magnification, KA shows thinner layers (E), but KA+TGB shows fibrous tissue and space enlargement 
(F) between cerebellar layers. A, D: sham group, B, E: KA group, C, F: KA+TGB group. Whole brain 
section 1.25X scale 1 mm; 10X magnification scale 200 µm.  
 
 
DISCUSSION 
The present study focused on kainic acid-
induced dystonia in the cerebellum. Four 
methods were used in this study, including 
the use of a dystonic phenotype table, EMG 
recording from the hind limb muscles, be-
havior-related task, and the histological sec-
tioning and staining of the cerebellar sam-
ples. Results obtained with this complex ap-
proach allowed us to conclude that symp-
toms observed in our rats following kainic-
induced cerebellar lesions could be classified 
as dystonia. 
Kainic acid microinjection induced the 
lesion only at the area of interest, while 
keeping the rest of the brain and peripheral 
tissues intact (Neychev et al., 2008). Im-
planting the telemetry electrodes at the ago-
nist and antagonist muscles measured the di-
rect response of muscle activity that correlat-
ed with animal behavior (Cesarovic et al., 
2011) when the dystonic spasm occurred.  
Cerebellum is mainly in charge of bal-
ance and equilibrium (Manto, 2006), and 
walking on the beam is one of the optimal 
behavioral methods to examine motor imbal-
ance (Carter et al., 2001). 
After 4 assessments of the tiagabine-
treated group (KA+TGB) and the non-
treated (KA) group, there was a progressive 
amelioration in the beam walking locomo-
tion (Figures 5 and 6), in time to complete 
the task, the covered distance on the beam. 
EMG data also showed significantly differ-
ent amplitudes recorded from TGB-treated 
and non-treated groups (Figure 4). There was 
partial cerebellar layer degeneration in the 
serial sections, compared to the sham-
operated group (Figure 7). With the motor 
improvement in beam walking, the distinct 
but minor cellular plasticity in the cerebellar 
layer might be the reason for the rats walking 
smoothly with perfect balance on the beam 
bridge again. The results of this study corre-
spond with and confirm our hypothesis. 
Moreover, tiagabine was also i.p. injected in-
to the lesion rats. The drug might have addi-
tionally been diffused to other GABAergic 
neurons and interfered with their transmis-
sion. We have no clear knowledge as to 
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whether the motor improvement is from the 
lesion area, from the intact regions of the 
cerebellum or from the other brain regions 
involved with motor activity. In addition, 
there was an overlap between the KA group 
and the KA+TGB group at 100 minutes post-
kainic acid injection. Although this result 
correlates with the EMG result at 90 
minutes, the result was different from previ-
ous studies (Pizoli et al., 2002), where rats 
displayed little locomotor activity after 120 
minutes of observation. Perhaps longer time 
might be needed for the dystonic rats.  
Efficacy of tiagabine post-lesion treat-
ment was also demonstrated in this study. 
Unlike pre-lesion treatment (Lin et al., 
2013), we applied the drug only when we 
had confirmed the degree of dystonic stiff-
ness and rigidity in the preliminary study 
(Figure 2). In other words, it’s rational to ap-
ply the treatment after dystonia diagnosis. 
 
CONCLUSION 
Overall, dystonia is not just a basal gan-
glia disorder. It is associated with the dys-
function of the motor circuit of the cerebello-
thalamo-cortical tract. The cerebellar lesions 
determine the symptoms of dystonia. In this 
study, we demonstrated that the cerebellar 
dysfunction might lead to dystonia. Tiaga-
bine, GABA-uptake inhibitor, might be a 
possible therapeutic treatment for cerebellar 
dystonia. The development of therapeutic ef-
fects may need more investigation. However, 
our study confirms that the animal model of 
dystonia, evoked by a small dose of kainic 
acid, is sufficient to induce cerebellar dysto-
nia, which corresponds with previous stud-
ies.  
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